C4K Announces New Medical Director

Joseph Lasky

Cure 4 The Kids Foundation Announces New Medical Director

LAS VEGAS – October 4, 2022 – Cure 4 The Kids Foundation (C4K), Nevada’s only pediatric cancer and rare disease treatment center, has announced Joseph Lasky III, M.D., is being promoted from Director of Pediatric Neuro-Oncology to Medical Director.

In his new position, Dr. Lasky will lead the organization’s team of physicians, oversee clinical quality and patient safety, and assume responsibility for the clinical research initiatives at Cure 4 The Kids Foundation. He will also provide leadership in collaboration with community partners. 

“Over the last five years, the organization has benefited from Dr. Lasky’s outstanding leadership and dedication to providing compassionate and innovative care to our fragile patient population,” says Annette Logan-Parker, Founder and CEO. “I am confident that in his new role, he will continue to advance the mission and vision of the organization.”

Dr. Lasky has more than two decades of clinical and research experience. Before joining C4K, he led the pediatric hematology/oncology program at Harbor/UCLA Medical Center and held several academic positions. Currently, he holds professor positions at UNLV and Roseman University of Health Sciences. Since joining C4K in 2017, Dr. Lasky has been treating a wide range of children with pediatric cancers and rare diseases, all while overseeing the organization’s Neuro-Oncology and Bleeding and Clotting Programs. 

Dr. Lasky is board certified in pediatric hematology/oncology and is a member of several professional organizations, including the Children’s Oncology Group, Society for Neuro-Oncology, American Society of Hematology, and the American Academy of Pediatrics.

With this promotion, Dr. Lasky will become the highest-ranking physician within the organization and will assume the responsibilities of Dr. Alan Ikeda, M.D., who is scheduled to retire as the organization’s Chief Medical Officer in mid-November 2022. Dr. Lasky and Dr. Ikeda will continue to work collaboratively as Dr. Ikeda will remain a C4K Advisory Council member. Dr. Ikeda joined C4K in 2011 and has worked tirelessly to raise the bar of clinical standards within the organization and throughout the Las Vegas pediatric medical and research community. He has been instrumental in guiding the clinic through exponential growth and expansion of patient services over the past decade. 


“It has been an honor and privilege to work side-by-side with Dr. Ikeda in building the clinical infrastructure of C4K. We plan to continue his legacy of clinical excellence and honor his hard work and dedication,” said Dr. Lasky. “He has left an impressive mark on the patient experience and, more importantly, the patient outcomes. I’m thrilled to be leading the team of professionals that he built, a team that is curing pediatric cancer every day right here in Las Vegas.”

Share This Post

Explore More News


Rare Disease Advisory Council seeks input for healthier Nevada

The Rare Disease Advisory Council is seeking input from the public to help improve the health of Nevada residents. The council is focused on addressing the needs of those with rare diseases and is looking for feedback from patients, caregivers, and healthcare providers. The goal is to gather information that can be used to develop strategies and policies to improve the lives of those affected by rare diseases in Nevada.


Cure 4 The Kids Foundation Announces Senior Leadership Changes

Cure 4 The Kids Foundation is pleased to announce the appointment of Christine Tonn as its new chief executive officer (CEO), effective January 1, 2024. This promotion is part of a board of directors-supported management succession plan.